Clinical Studies and Trials

NEAT

Comments Off on NEAT

This trial will evaluate the effects of EryDex in patients with A-T.

More

Betamethasone Trials

Comments Off on Betamethasone Trials

These trials studied whether a low dose betamethasone would reduce neurological symptoms associated with A-T.

More

Effect of Amantadine on Movement Disorder in A-T

Comments Off on Effect of Amantadine on Movement Disorder in A-T

This trial was performed to see if amantadine sulphate improves ataxia or other movement disorders associated with A-T.

More

Cerebrospinal Fluid Biomarker Study

Comments Off on Cerebrospinal Fluid Biomarker Study

Among the 204 identified CSF proteins, 13 showed significant changes in A-T patients versus control samples.

More

OxiDative Stress Clinical Trial

Comments Off on OxiDative Stress Clinical Trial

Two laboratory markers of oxidative stress improved when participants took both alpha-lipoic acid and nicotinamide.

More

L-Dopa Treatment Trial

Comments Off on L-Dopa Treatment Trial

No overall consistent improvement in neurologic function was observed on L-Dopa.

More

Global A-T Family Data Platform

Comments Off on Global A-T Family Data Platform

The Platform is a patient-driven effort through which data about people with A-T are shared with researchers.

More

Pulmonary Function Study

Comments Off on Pulmonary Function Study

This study seeks to establish the natural history of pulmonary function decline in the A-T population.

More

Nicotinamide Riboside (Niagen) Proof-of-concept Study

Comments Off on Nicotinamide Riboside (Niagen) Proof-of-concept Study

This trial in the Netherlands looked at the effects of nicotinamide ribose as a potential treatment for people with A-T.

More

PET Scan/FMRI Study

Comments Off on PET Scan/FMRI Study

Participants with A-T demonstrated lower brain activity or metabolism in the cerebellum as compared to control participants.

More